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MP Murraya paniculata
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PG prostaglandin
TE buffer tris-EDTA buffer
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ABSTRACT
The effects of Murraya paniculata extracts
on implantation were investigated in the rat. Oral
administration of MP-EtOH in a minimum of 15 gm DWE was
effective in suppressing pregnancy. The effective dosage
of chloroform and butanol fractions were 20 and 60 gm DWE,
respectively. The anti-implantation activity was most
prominant when given on PD1-2 and is not active on PD3 or
thereafter. Ovum implantation was delayed for approximately
24 hrs. Like the effect of estrogen, the plant extract
produced a sustained increase in uterine weight in intact
or ovariectomized immature rats. It also stimulated vaginal
cornification in both pseudopregnant and ovariectomized
rats. MP acted as an estrogen agonist in producing long
term retention of nuclear estrogen receptor, parallelled
with a full replenishment of cytoplasmic receptor, which
in turn stimulated uterine growth. Decidualization was
suppressed by a minimum of 10 gm DWE of MP-EtOH. This
inhibition was all or none in nature. Concentrations of E
2
in serum were significantly reduced in MP treated rats on
PD3 and PD5. On the other hand, a significant increase in
serum concentrations of t'P were observed on PD5. A
single injection of E2 at 1100 or 1600 hr on PD2 or PD
4'
failed to abolish the anti-implantation effects of MP.
The plant materials exhibited no adverse effect on the
development of the fetuses and normal mating and pregnancy
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Much time and effort has been devoted to the
search for anti-implantation agents with the idea that these
might prove to be acceptable postcoital contraceptive
substances in humans. Precoital techniques involve some
waste of contraceptive effort, require premedication, often
have unwanted side effects, may have anti-esthetic and anti-
erotic aspects, and are not as yet infallible. Many studies
have been concerned with the hormonal aspects of the pre-
implantation peroid, others have concentrated on changes in
cellular functions and relationships. Part of the direction
behind this kind of research has been the idea that collect-
ion of sufficient information about the specific processes
involved would allow the development of an agent which could
block the implantation process specifically without producing
a systemic effect.
Many of the chemical compounds which are
effective as postcoital contraceptive agents are not in true
sense anti-implantation agents, since the number of compounds
which specifically inhibit implantation are very limited.
Some compounds exert effects on this stage and also on other
early preimplantation processes such as egg transport or egg
development. In the present study, the term anti-implantat-
ion has been broadened to include antifertility effect
between fertilization and implantation.
2The folklore of many cultures includes
descriptions of potions, usually of plant products, that can
act as abortifacients. Although these have not been scientific-
ally validated, reports appear persistently in antropological
literature. Murraya paniculata, when used postcoitally, is
effective in suppressing implantation. It may impair
further development of the fertilized ova, either by a
direct embryotoxic effect, or indirectly, by altering the
rate of tubal transport, or render the uterine environment
unfavourable for implantation. In the present study, special
emphasis has been put on the elucidation of the mechanism
involved. This work was extended to include the assays of
estrogenicity, determination of steroid hormones levels,
binding capacities of the cytoplasmic and nuclear estrogen
receptors and the studies of the development of endometrial
sensitivity, the effect on subsequent pregnancy, as well as
the teratogenicity of the plant.
1.1 Endocrine control of ovum implantation
1.1.1 Role of progesterone
In a historical context the first hormone
shown to be involved in implantation was progesterone. In
the vast majority of species there appears to be an absolute
requirement for progesterone, and removal of the source of
the hormone results in failure to implant (Corner, 1928),
although the blastocysts may remain viable for several days
(Weitlauf & Greenwald. 1968).
31.1.2 Role of luteal phase estrogen
Krehbiel (1941) and Weichert (1942) found
that implantation. could be precipitated in lactating rats
by the administration of a small dose of estradiol. This
results suggest a role for estrogens in implantation. It was
demonstrated that a condition of artifical delayed implantat-
ion could be induced in pregnant rats by ovariectomy before
implantation, followed by administration of progesterone. If
a small quantity of estrogen is given in addition to progester-
one, then implantation occurs at the normal time (Cochrane
Meyer, 1957). These findings lead to the hypothesis that a
surge of estrogen occurs on the third day of pregnancy and
is responsible for implantation (Shelesnyak et al., 1963).
It is known that the uterus in rats is sensitized for im-
plantation by a surge of estrogen secretion occurring on day
4 of pseudopregnancy (Shaikh Abraham, 1969) or pregnancy
(Yoshinaga et al., 1969 Shaikh, 1971). In the mouse, estrogen
peak was observed between 1000 and 1200 hr of day 4 and was
significantly different from the samples taken at other times
(McCormack Greenwald, 1974). In rats, ovariectomy and
progesterone replacement before this estrogen surge results
in delayed implantation (Psychoyos, 1963 Zeilmaker, 1963).
1.1.3 Role of estrogen secreted before ovulation
It was reported that implantation could be
obtained from the transfered blastocysts without priming the
4ovariectomized recepients with estrogen before progesterone
treatment (Humphrey, 1969). This indicated that priming is
not essential for implantation in the mouse. However, the
number of implantation sites was very small and evidence
from experiments using the decidual cell reaction suggests
that estrogen priming is neccessary to obtain a full reaction
in the stroma, comparable to that which can be elicited in
pseudopregnancy (Finn, 1966 Finn Martin, 1970). Without
priming, only a small response is obtained. It thus seems
a reasonable assumption that the estrogen secreted during
proestrus plays a small, if nonessential, part in inducing
uterine sensitivity to implantation.
To summarize, it is established in the rat
and mouse that the pattern of hormone secretion during early
pregnancy brings the endometrium into a state of sensitivity
which is necessary for the implantation of the ovum.
1.1.4 Role of the' pituitary and hypothalamus
The secretion of the ovarian hormones is
controlled by the pituitary hormones and which in turn are
under the influence of the hypothalamus. The involvement of
the brain has been shown by the destruction of certain areas
of the hypothalamus and the systemic administration of neuro-
leptic drugs (Bindon, 1969). Ergot alkaloids and related
chemicals also inhibit implantation by an effect on the
hypothalamus (Mantle, 1969 Mantle & Finn, 1971). There seems
5to be little doubt that prolactin is secreted in early
pregnancy, with the major peak in the plasma between As to
60 hr after mating (Morishige et al., 1973 Watson et al.,
1975). Ergot alkaloids are known to suppress prolactin
secretion (Doehler Wuttke, 1974) and injections of the
hormone, or progesterone, will reverse the antifertility
effect of the drugs (Mantle Finn, 1971). There is evidence
that luteinizing hormone (LH) is also involved in the
control of progesterone secretion. Antisera to LH will
prevent implantation in mice and the effect is reversed by
injections of LH or progesterone (Madhawa Raj et al., 1968,
Loewit Laurence, 1970). In the mouse, an increase in LH
secretion occur with a peak on day 4 of pregnancy, but the
level of follicle stimulating hormone (FSH) remain low
before implantation (Murr et al., 1974). An injection of LH
will precipitate implantation in hypophysectomized rats
maintained in delay with progesterone injections (McDonald
et al., 1967).
Corpora lutea of the estrus cycle in the
rat are non-functional in the sense that they do not secrete
enough progesterone to prepare the uterus for acceptance of
fertilized ova. In pregnant rats, corpora lutea are made
functional by the mating stimulus. Prolactin and LH are the
chief components of the pituitary luteotrophic complex
during the first half of gestation, causing the corpora
6lutea to secrete progesterone (Smith et al., 1975 Madhawa
Raj & Moudal, 1970). If the corpora lutea of pregnancy are
to maintain a relatively high secretion rate of progesterone
corpora lutea responsible for the conversion of progesterone
to 20a dihydroprogesterone, must be suppressed. Prolactin,
which inhibits this enzyme, and LH which stimulates
steroidogenesis, thus regulate the activity of the corpora
lutea (Hashimoto Wiest, 1969). LH was shown to deplete
ovarian cholesterol stores and to stimulate progesterone
and 20a dihydroprogesterone synthesis and release (Armstrong
et al., 1964 Behrman Armstrong, 1969 Hilliard et al.,
1964). Prolactin alone is ineffective as a stimulus of
steroid hormone synthesis (Huang Pearlman, 1962 Marsh
et al., 1966). In the rabbit, prolactin was shown to
increase the storage pool of cholesterol in the ovary
(Hilliard et al., 1968) and in the rat it was shown that
prolactin prevent the conversion of progesterone to 20a
dihydroprogesterone by inhibiting the 20a dihydroxysteroid
dehydrogenase (.Weisz et al,, 1968). Prolactin, however, has
a permissive action upon progesterone biosynthesis. A
greater stimulatory effect of LH was observed in the presence
of prolactin (Armstrong, 1969).
In the rat, however, FSH is required to
induce implantation. The activity of FSH is mediated by the
20a hydroxysteroid dehydrogenase, a soluble enzyme in the
7ovarian follicles, possibly for the enhancement of estrogen
secretion (Raud, 1974). This concepts fits well with recent
reports that FSH stimulates estrogen synthesis in the
ovarian culture and in the granulosa cell incubation system
(Moon et al.,) 1975).
1.2 Decidualization
The function of the uterus is to accomodate
and to form a structural union with the developing young. In
response to the presence of an embryo, the tissues of the
uterus undergo considerable transformation into characterist-
ic type of cell, the decidual cell. The presence of large
quantities of glycogen and fat in decidual cells suggests
that the decidua may have a nutritive function. Following
activation and attachment, the embryo grows rapidly and a
readily available source of carbohydrate might be advantage-
ous. The blood vessels in the decidua are very well develop-
ed and in close contact with the decidua. Substances
synthesized in decidual cells might pass into the sinusoids
and be taken directly to the embryo (De Feo, 1967).
During most of the reproductive cycle in
mammals, the endometrium is refractory to implantation. The
uterus will permit the blastocyst to implant only for very
brief peroids, during which it is said to be sensitive or
receptive. It may be that implantation follows the sequence:
estrogen priming, progestational changes, estrogen action,
8sensitization, blastocyst or artificial trauma, transfer of
information to stromal cells, stromal cell transformation
(i.e. to decidual cell Porter Finn, 1977). The early
stages of implantation and decidualization thus involve a
complex interplay among the hormones of the ovary, the
endometrium and the blastocyst, triggering of the uterus
and attachment of the trophoblast to the uterine epithelium.
It is clear that the ovarian hormones start the process going,
but the seuqence of events and their control after that are
very difficult to antangle.
1.2.1 Artificial decidual formation
It was discovered that it is possible to
provoke the decidual transformation in the uterus of the non-
pregnant animal by artificial stimulations (Leob, 1908). The
discovery makes possible critical investigation of the
physiological factors, permitting the uterus to respond to
stimuli and, undergo decidualization without the complications
contributed by the presence of fertilized ova, at the same
time permitting analysis of the separate role of the ovum
and uterus (Finn, 1971). Artificial stimuli, both chemical and
mechanical lesion, have been shown to be potent evokers of
the decidual reaction. The rat endometrium can be induced to
undergo decidualization if it is traumatised such as crushing
at the appropriate time in the cycle (Selye Mckeown, 1935).
Various substances have been tested for the ability to initiate
9a decidual cell response when injected into the uterus of
a pseudopregnant animal. Of many substance tested in the rat
by Finn Keen (1963), only two classes of solution initiated
a reaction, they are oils and sulphated polysaccharides (agar,
carragenin and heparin). The injection of a small quantity of
oil into the uterus of pseudopregnant rat provides a simple
method for studying the effect of the drug to decidual
stimuli. Because the oil is inert and unaffected by hormones,
it can be assumed that it gives a constant nidatory stimulus
to the uterus. The use of oil as a decidual stimulus has
therefore some obvious advantages, although it must be
admitted that its usefulness depends to some extent on the
assumption that the stimulus given to the uterus by oil is
similar to that provided by a blastocyst (Finn, 1965). This
assumption cannot be proven at present as the nature of the
stimulus in either case i s 1lnknnTAm
1.2.2 Role of estrogen in decidualization
An important feature of the action of
estrogen in the preparation of the uterus for implantation or
3ecidualization is the biphasic nature of the response.
sensitization occurs when small doses are given, but with
Larger doses inhibition occurs (Nutting Meyer, 1963 Finn,
L966 Smith Biggers, 1968). Thus, the decidual reaction can
be prevented in pseudopregnant rats and mice by the administrat-
ion of estrogens (Rothchild et al., 1940 Rothchild Meyer.
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1942; Velardo & Hisaw, 1951). Similar, in pregnant rats and
mice it is simple to interrupt pregnancy by treating the
animals with estrogens just before implantation (Parkes et al.,
1938; Dreisbach, 1959).
1.3 Estrogen receptor binding and relationship to uterine
growth
It is well established that estrogen
stimulate cellular hypertrophy and uterine hyperplasia,
thereby increasing uterine weight. Once inside the cells of
the target organ, estrogens act by influencing the trans-
cription of information in the nucleus with the formation of
new RNA, which then induces enzyme synthesis in the cyto-
plasm (Hamilton, 1968) and initiate morphological changes
in the endometrium.
The initial events accompanying estrogen
uptake by cells of estrogen-responsive tissues had been
studied extensively (Gorski et al., 1968 Jensen DeSombre,
1972; O'Malley & Means, 1974). The current model for estrogen
in target tissues indicates that.after entering a target
cell, the hormone binds to high affinity cytoplasmic receptor
to form a complex which then enters the nucleus. Considerable
evidence suggests that the presence of the receptor-estrogen
complex in the nucleus is a prerequistite for stimulation of
many estrogen-induced biosynthetic events (Katzenellenbogen
Gorski, 1972; Clark et al., 1973; Ruh et al,, 1973). However,
the nature of the events that are stimulated by an estrogen
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in the immature rat uterus depends not only on the quantity
of nuclear receptor complex but also on its duration in the
nuclear compartment (Anderson et al., 1975).
Maximal uterine growth correlates with
the number of nuclear receptor-estrogen complex that undergo
long term retention. This-long term nuclear retention of the
receptor-estrogen complex will initiate a series of early
and late uterine responses. Early responses include water
imbibition, hyperemia, amino acid and nucleotide uptake,
activation of RNA polymerase I and II and stimulation of
protein synthesis, whereas late responses include cellular
hypertrophy and hyperplasia, sustained RNA polymerase I and
II activity (Clark et al., 1973 1974 Rochefort et al., 1972).
The retention of the nuclear receptor-
estrogen complex is accompanied by a rapid replenishment
(possibly via recycling and resynthesis) of the cytoplasmic
receptor within 24 hrs. This replenished cytoplasmic receptor
is then free to interact with estrogen to form receptor-
hormone complexes which bind to nuclear sites and cause a
second cycle of uterine growth stimulation (Katzenellenbogen &
Ferguson, 1975).
1.4 Agents with anti-implantation effects
The successful initiation of blastocyst
attachment is dependent upon the precise synchronization of
endometrial, embryonic and ovarian function during the first
12
few days of pregnancy. The finely balanced nature of the
mechanisms controlling implantation render this stage of
development particularly susceptible to contraceptive
attack. Several possible routes have been suggested:
1.4.1 Compounds affecting egg transport
The egg transport phase in the oviduct of
most species occupies the first three or four days after
ovulation (Croxatto et a1., 1972 Harper et al., 1960).
During the first day, while under estrogen domination, the
eggs move quickly through the thin walled ampulla. Under a
delicate balance of endogenous estrogen and progesterone,
the eggs are held at the ampullary-isthmic junction until
fertilized and then descend through the muscular ampulla to
enter the uterus via the uterotubal junction. The eggs then
move freely in the uterus until attachment (.Bennett, 1975).
Steroidal estrogens (Chang Harper, 1966), and antiestrogens
(Spona et al,, 1972), gonadotrophins (Harrington, 1965),
prostaglandins (Ellinger Kirton, 1972), autonomic drugs
(Pauerstein et a1,, 1973 Bennett Kendle, 1967) and a
large number of non-steroids act to accelerate or retard
the rate of egg transport.
Ovarian steroid hormones have a major
regulatory influence in the transport and normal develop-
ment of zygotes in the oviduct. Estrogens increase the
rate of secretion of tubal fluid (Mastroianni et al., 1961),
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are prerequisites for ciliary growth and movement at the
ostial portion of the tube, and tend to increase the
frequency and decrease the amplitude of tub al muscle
activity (Hafez, 1975). Progesterone, in the presence of
estrogen, tends to decrease the frequency of contraction
and increase the amplitude. The overall effect of the
ovarian steroids is to alter the responsiveness of the
tubal musculature to local release of adrenergic agents
(norepinephrine, Coutinho et al., 1970). Upsetting the
proper sequence in the hormonal environment can therefore
alter moltility and disturb the normal passage of cleav-
ing ova in the oviducts (Segal & Nelson, 1958). This has
been demonstrated by many experiments, but species
differences and variations in experimental techniques
have made it difficult to construct a unified concept
form reported observations,
In the view of the universality of
estrogen effects on the oviduct and egg transport, it
is perhaps not suprising that estrogens and antiestrogens
are equally effective, In mice, the predominant anti-
fertility effects of antiestrogens are to cause tubal
retention of eggs, It was discovered that antiestrogens
such as DES, MER-25, MRL-37, when given on days 1 to 3
of pregnancy, caused both retard transport and delayed
development of eggs (Humphrey & Martin, 1968). Since all
14
these compounds exert some estrogenic activity (Emmens,
1965a 1965b Emmens Martin, 1965 Greenwald, 1965),
their effects on egg transport are due to its estrogenic
property and not to their antiestrogenic properties.
A general held theroy is that changes
in the rate of egg transport produced by a drug-induced
alternation of endogenous estrogen level, producing a
desynchronization of the biochemical and transport re-
lationship between the egg and the reproductive tract, with
consequent degeneration of the egg,
1.4.2 Compounds *affecting egg development
It was generally concluded that most
of the compounds which exert a direct effect on the develop-
ing egg are those which are highly toxic for all rapidly
dividing cells (Harper, 1968b), Some compounds developed
for cancer chemotherapy have been tested in pregnant animals.
It is not suprising that oncolytic agents are able to
interfere with the growth of embryonic as well as cancer
cells. Methotrexate, 6-mercaptopurine are oncolytic drugs
that produce remissions of trophoblastic tumors. Many
compounds that act as mitotic poisons, inhibitors of protein
synthesis, or antimetabolites will cause resorption or
abortion of implanted embryos in experimental animals
(Thiersch, 1962).
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1.4.3 Compounds affecting function of the corpus luteum
In all species studied, a successful
intrauterine pregnancy requires sufficient progestational
support of the endometrium, both for preparation for
nidation and for maintainance of the placenta. Early
pregnancy requires adequate corpus luteum function. After-
ward placental production of progesterone is capable of
maintaining pregnancy in the absence of the ovaries. Several
classes of compounds have been studied for their ability to
suppress luteal phase progesterone, three approaches have
been suggested:
1.4.3.1 The disruption of luteal function by inhibiting
the early luteotrophic activity of the blasto-
cyst
In women, the early conceptus exerts
a direct luteotrophic factor, human chorionic gonadotrophin
(hCG), which starts to rise about one day after implantation
(Jaffe et al., 1969 Saxena et al., 1974) and quickly
stimulates a rise in the plasma progesterone levels (Hanson
et al., 1971 Niswender et al,, 1972). By blocking the action
of such factor, it should be possible to arrest pregnancy
of the attachment stage. In order to acheive this objective,
immunogens are being developed for the active immunization
of women aganist chorionic gonadotrophin (Bahl et al., 1976).
The key to a possible immunological approach to contragestat
16
ional activity is the selection of a specific antigen that
will not cross react dangerously with other tissue antigens
and that will selectively interfere with a critical event
in the reproductive sequence. Another approach involves the
development of antihormones to compete with hCG for receptor
sites on the corpus luteum. These compounds might be
administered in the event of a missed menses, or on a once--
a-cycle basis at the expected time of menstruation, to
induce luteal regression.
1.4.3.2 The disruption of luteal function by interfering
with progesterone receptors in the endometrium
High affinity receptors for progester-
one have been identified in the uterine cytosol of the calf,
guinea pig, human and rat (Thomas, 1973 Milgrom et al.,
Milgrom Baulieu, 1970). The manipulation of receptor
function offers great promise for the development of new
contraceptive agents. Antiprogestins, such as 16a-bromo-
acetoxy-progesterone and R-2323 are currently being sought
which posscess the ability to compete with endogenous
progesterone for uterine binding sites, but lacks progestat-
ional activity. These compounds could be used on a once-a-
cycle basis to saturate the large number of free receptor
sites present in the endometrium during the late proliferat-
ive phase.
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1.4.3.3 The disruption of luteal function with prosta-
glandins or steroids which act directly on the
corpus luteum
The mechanism by which PGF2a induces
luteal regression is poorly understood. In rats and mice, an
important step in PG induced luteolysis appears to be the
activation of an enzyme, 20a hydroxysteroid dehydrogenase,
which catalyses the conversion of progesterone to a biologic-
ally less active derivative, 20a dihydroprogesterone (Fuch &
Mok, 1974).
Estrogenic compounds have been found
to induce luteolysis in laboratory animals (Guinea pig,
hamster, rabbit and rat, Oriol-Bosch & Cortes, 1975).
Systemically administered estrogens are also known to
exert a powerful antifertility effect. There is some
evidence to support a luteolytic mode of action (Gore et
al., 1973).
1.4.4 Natural products
Abortifacient substances have been
found in various plants, but frequently the abortifacient
activity can be ascribed to estrogenicity. This is probably
the explantation of the activity of pine needle (Pinus
sylverstris) extracts and subterranean clover (Trifolim
subterraneum) in causing fetal resorption in animals.
Mexican women are believed to use a plant called Zoapatle
(Montanoa tuberosa) to induce abortion (Segal, 1977). Here
18
again estrogenicity may be involved, but a compound with
oxytocic properties may also be present.
1.5 Murraya paniculata
1.5.1 Botany
Murraya, belongs to the Rutaceae, is
frequently used in landscape gardening for its dark, glossy,
green foliage, white fragrant flowers and rich-red fruits.
Depending on the taxonomic opinions of various taxonomists,
there are about six to sixteen species in the genum Murraya.
The differences in opinions are mainly due to the wide range
of variation in morphology among many species, compounded
with the artificial selection of horticultural strains. Six
species are found in China, namely M. alata, M. euchresti-
folia, M. keonigii, M. microphylla, M. paniculata (M. exotica),
and M. tetramera. M. euchrestifolia is endemic to Taiwan,
while M. tetramera is found only in Yunnan.
Distribution of the Murraya species
has a distribution center in southern China and the several
countries connected to the southwest border of China, and
spreads to India, Sri Lanka in the west, and Phillipines
and Indonesia in the east.
A simple botanical description of M.
paniculata Linn. Jack (syn. M, exotica) reads as follows:
an evergreen shrub or small tree with very hard wood,
sometimes attaining 15 ft in height. Glabrous with the
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young parts soft-hairy. Leaves lustrous green, 4-6 inches
long, with 3-9 leaflets, rarely reduces to one leaflets
oval-shaped, shortly pointed, 3/4 to 1/2 inches long.
Flowers white, fragrant formed in tight terminal clusters
during the summer. Although each individual flower is
less than 1/2 inch in daimeter, they create a mass effect
because of their abundance. Fruit, round, one to two seeded
berry, bright-red, 3/4 inch in diameter.
1.5.2 Phytochemistry
Pharmacognostical work on M. species
have been carried out since 1965. Twenty alkaloids were
isolated from three M. species, including M. paniculata
(Mester, 1973; 1977). By the end of 1979, at least six more
alkaloids have been identified (Chakraborty et al., 1978
Fauvel et al., 1978; Ganguly Sarkar, 1970). In 1978, Gray
and Waterman (1978) reported that twelve coumarins have been
found in different parts of M. paniculata. In addition, two
coumarins, viz., auraptene and imperatorin were missed in
this list (Ganguly et al,, 1977; Sanyal et al., 1975). Up
to now, chemical works were mainly concentrated on the
aerial parts, i.e., leaf, flower, fruit and stem. Only one
report concerning the chemical composition of the root of
M. paniculata was found (Fauvel et al., 1978).
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1.5.3 Ethnomedical information
In traditional Chinese medicine, M.
paniculata was used for the asperation of vital energy
（ 行 氣 ） invigoration of the circulation and
the dispersion of the extravasated blood (Anon,（ 化 瘀 ）
1977). In Singapore and Java, the aqueous decoction of the
leaves of M. paniculata is used to cure abnormalities in
female reproductive functions (Kan, 1972). It can also be
used as emmenogogue (Cheung, 1970). The application of M.
paniculata for the treatment of diarrhoea, dysentary,
dropsy was reported by Chopra et al. (1956). M. koenigii
Spreng, a related species, is used in Indian folklore
medicine as an antiperoidic( Gupta & Nigam, 1971).
1.5.4 Pharmacology and clinical reports
A colourless crystalline non-nitro-
genous compound was isolated from the petroleum ether (60°-
80°C) extract of the leaf of M. paniculata. This compound
has a relaxation effect on rat ileum, antagonize the
histamine induced contraction but not the acetylcholine
induced response. No significant effect on blood pressure or
respiration was observed on anaesthetized dog (Anon, 1970).
50% ethanol extract of M, paniculata has been used as local
anaesthetics for gastrectomy (Anon, 1970) and tonsillect-
omy (Anon, 19.71).
Clinical use of the aqueous extract of
（ 活 血 ）
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the root of M. pan iculata for ecobolic has been reported by the
Chinese scientists. The drug was applied intracervically to




2.1 Effects of MP extracts on implantation
2.1.1 Animals
Sprague-Dawley Rats strain, originated from
Charles River, were raised in Science Center, The Chinese
University of Hong Kong. They were housed in animal
quarters with artificial illumination from 0900 to 2100 hr
daily. Vaginal smears were examined daily. Proestrus
females were caged overnight with proven males. The
appearance of spermatozoa in the vaginal smear in the
following morning was taken as the first day of pregnancy
(PD1). Animals received graded doses of MP extract on
different days of pregnancy. Doses were administered
intragastrically (ig) in a maximum volume of 1 ml/day
The extract were dissolved in vehicle (ethanol/Tween 80/
water: 2/1/7 v/v). Each dose was quantitated as the
extract prepared from unit dry weight of MP. Control
groups either received similar volume (1 ml) of the
appropiate vehicle or not treated at all. All animals
were autopsied at 1200 hr on PD8. The number of live
implantation sites were recorded. The length of the long
axis of the implantation site was measured using a cali-
brator. Any animal having at least one or more implanted
embryos was considered as pregnant. All animals, before
and after mating were maintained on uniform husbandry
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conditions They were fed on a standard Purina laboratory
diet with drinking water ad libitum.
The biological activity of the alcohol
extract was tested in the Worcester Foundation for Experi-
mental Biology, Charles River CD rats were used. These
pregnant females were subjected to similar treatment
schedule. Autopsy was performed on PD8.
2.1.2 MP extracts preparation
The plant materials were obtained from various
sources, some were cultivated in the University campus,
some were purchased from Chiangmai or China. The air-dried
root was washed in tap water to get rid of soil. It was
cut into small chips with a garden shear and grounded into
a coarse powder. The root was percolated with distilled
water or refluxed in 70% ethanol. Detailed extraction and
purification procedures were outlined in figure 1. Only
the root of MP was used in this work. The quantity of
various extracts were referred to dry weight equivalent
(extracted) from unit weight of starting material. The
origin of each batch of extract varied but the effective
dose is fairly constant at 20-30 gm/PD 1-4 The alcohol
extract of MP root was disignated MP-EtOH, the same applies
to MP-CHC13 (chloroform) etc.
2.1.3 Delayed implantation
The onset of implantation was determined by the
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Dry root of MP
refluxed with 70% ethanol at 70°C
filtered
mart filtrate
discarded concentrated under reduced pressure
MP-EtOH
partition between water partition between water
and butanol and chloroform




Fig.1 Outline of the extraction procedure of NP
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i. v. injection of 0. 2 ml 370 pontamine sky blue 6BX (Hopkin
Williams) in 0.9% (w/v) NaCl solution 10 to 15 minutes
before sacrifice the animal (Psychoyos, 1971).
Animals were treated with MP-EtOH on the morning
of PD1 and PD2 (5 gm DWE daily). Control animals received
the vehicle alone. Groups of treated and control animals
were killed at different time points on PD5 or PD6.
2.2 Assays of estrogenic activity
2.2.1 Vaginal cornification
Adult virgin rats, ovariectomized about 14 days
before the experiment, were dosed daily for 6 days (day 1
to 6). Vaginal smears were taken each morning from days 1
to 7 inclusive, and also in the late afternoon (1600 hr) of
day 4. Smears were classified as cornified which were
composed of cornified and/or nucleated epithelial cells with
no more than the occasional leukocyte. Rats which had a
cornified smear at any time during the last 3 days of test
were considered to have positive response.
2.2.2 Uterotrophic response
Immature female rats of 21 to 23 days old were
used. Each test group comprised 5 animals. Ovaries were
removed on day 1 of experiment and drug administration
commenced on the same day. Group 1 received 1 ml vehicle
daily (Ethanol/Tween 80/water: 2/1/7). In group 2, 2.5 ug/
day estradiol-17B was given subcutaneously whereas in
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group 3, MP extract was given at a dose level of 1 gm DWE/
day. Treatment continued once daily for 3 days and on the
fourth day the animals were killed and their uteri excised,
blotted and weighed.
The increase in mean uterine weight per animal
was used as an index of uterotrophic effect.
2.2.3 Labeled estradiol exchange assay: Actions of MP-
EtOH on the levels of uterine estrogen receptor
and uterine growth
Estrogen receptor in the cytoplasmic and
nuclear compartments were determined by the labeled estradiol
exchange assay (Katzenellenbogen et al,, 1973 Anderson et
al., 1972) with slight modification (Katzenellenbogen, 1975).
Immature female rats of 21-23 days old were
grouped and treated according to the following experimental
design. Rats were injected subcutaneously with saline
(control), or 2.5 ug estradiol (E2), or 2 gm DTWE MP-EtOH
extract intragastrically (MP) or a combination of estradiol
and MP-EtOH (MP+E2). Two groups received one dose were
sacrified respectively at 24 hrs or 48 hrs later. A third
group received two doses 24 hrs apart were sacrified at
24 hrs after the second dose.
Animals were killed by cervical dislocation,
uteri were rapidly removed, trimmed, weighed and placed in
ice-cold Tris-EDTA buffer (lOmM Tris-HC1, 1.5 mM EDTA, pH 7.4,
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TE buffer). Uteri (3 per group) were rinsed with 20 ml TE
buffer and then homogenized with a Polytron (Kinematica PCU-2)
by three 5-sec bursts. The homogenate was centrifuged at
800 x g for 20 min to yield a nuclear pellet and a low speed
supernatant, The nuclear pellet was washed 3 times, each with
2 ml cold TE buffer and followed by centrifugation at 800 x g
for 10 min. The washed nuclear pellet was then resuspended
in 13 ml TE buffer, The low speed supernatant was spun at
100,000 x g for 60 min in a refrigirated Beckman L3 ultra-
centrifuge with type 40 rotor to yield the cytosol fraction
which was further diluted to 13 mi.
0.8 ml of the nuclear fraction or cytosol
fraction were added to tubes containing 5 x 10 10M to
1 x 10 8M labeled estradiol-17B. The incubation volume was
1.0 ml. The nuclear fraction was incubated at 37°C for 30 min.
After the incubation period, tubes were placed in ice bath
for 10 min and 1 ml ice-cold TE buffer was then added. The
tubes were vortexed and spun at 800 x g for 20 min at 4°C.
The supernatant was discarded and'the pellet was washed 2
times with 3 ml ice TE buffer, each time was followed by
centrifugation at 800 x g for 10 min. The final pellet was
extracted with 2 ml ethanol. The ethanol extract was counted
in a Beckman LS-330 liquid scintillation counter. The amount
of radioactivity extracted by alcohol indicated the capacity
of the nuclear receptor.
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The cytosol fraction was incubated at 40°C for
18 hrs followed by the addition of. 0.5 ml charcoal-dextran
(10% v/v). The mixture was placed in ice for 10 min and then
centrifuged at 2000 x g for 10 min. The supernatant was
counted.
2.3 Actions of MP on decidual formation
Pseudopregnancy (PSP) was induced by
mechanical stimulation of the cervix in the evening of
proestrus and the morning of estrus EDe Feo, 1963a 1963b).
The day of vaginal cornification was designated as day 0
of PSP (PSP0). PSP1 was characterized by the first marked
appearance of leukocytes in the morning lavage. The stimulus
for deciduoma initiation was provided on PSP4 by 0.05 ml
arachis oil injected into the lumen of the uterus through
the top of the left uterine horn (Finn Keen, 1963). The
effect of MP on the decidual development was determined
in hooded rats administered a total dosage of 10 to 40 gm
DATE of MP-EtOH from PSP0 to PSP3.
Unilaterally pregnant rats were prepared by
ligating the left follopian tube on PD2. The left uterine
cornu was injected with 0.05 ml arachis oil on PD5.
The animals were anesthetized on the fifth
day after the injection of oil the uteri were removed and
split at the bifurcation point the mesentery was trimmed
off, and each cornu was weighed, cervix included, on a
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E. Mettler analytical balance. Rats with swellings in the
left horn were considered to have positive response and
the difference in weight between the two horns was taken
as an estimate of the magnitude of the response.
2.4 Determination of serum steroids levels by radio-
immunoassay
Blood samples (2 ml) were taken from the tail
artery under ether anaesthesia during 0900 to 1000 hr on
PD3 to PD5. No rats were bled more than 2 times. The blood
samples were left to clot at 4°C and 0.7 to 1 ml serum
aliquots were then stored in glass scintillation vials at
-20°C for deterimination of progesterone (4P) and
estradiol-17 (E2).
Measurement of 4P and E 2 in serum was carried
out after extracting once with 10 ml anhydrous ethyl ether.
Tritiated steroids (2,500 dpm for each steroid) were added
for the determination of recovery rate. The dried extract
was dissolved in 1.0 ml of iso-octane and steroids were
separated on micro-celite columns (Saksena et al., 1977).
The concentration of the steroids was determined by
radioimmunoassay (Saksena et al., 1976). The specifications
of the antiserum (anti-estrogen, gift from Dr. B .V. Caldwell,
and anti-progesterone, provides by Dr. G. E .Abraham) used
have been described earlier (Saksena et al., 1978).
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2.5 Effects of exogenous estrogen on MP treated rat
Experiment was carried out to determine the
effect of estradiol-17 , when supplement added, to prevent
the delay in ovum implantation.
A group of 6 rats were treated with MP-EtOH as
described in Expt 1. A single subcutaneous injection of
2.5 or 0.2 ug E2, dissolved in 0.2 ml arachis oil, was
given to these rats at 1100 or 1600 hr on PD2 or PD4. All
rats were autopsied on PD8 to examine for implantation
sites.
2.6 Study of the teratogenic effects of MP
2.6.1 Effects of MP on sex ratio of the fetuses
MP-EtOH extract was administered on PD1 and
PD2 in a total dosage of 5.0 gm DWE. Fetuses were examined
on any morphological abnormality or sex reversal presents
on day 3 postpartum. As the anogenital distance of the
male fetuses is greater than that of female fetuses
(Revesz et al., 1960), this serves a good criteria in
distinguishing both sexes.
2.6.2 Effects of MP on subsequent pregnancy
Animals were treated with two oral doses of
MP-EtOH extract (10 gm DWE/day) on the morning of PD1 and
PD2. Rats that were found not pregnant on the day of
laporotomy (8.days postcoitum) were resutured and cared
for. Upon the reappearance of a proestrus smear, they were
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caged with males of proven fertility. It has been shown
that a normal estrus cycle had returned and that mating
had occurred. The numbers and sizes of the implantation
sites in the experimental series were compared with those
of the controls according to the Student t test.
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3 RESULTS
3.1 Anti-implantation effects of MP extracts on pregnant
rats
3.1.1 Control group
Normally in control group, the average
number of viable implantation sites was 11.4, with a mean
length of 0.46 cm. The rats treated with vehicle from PD1
to PD4 were pregnant and unaffected on PD8, showing the
number of a mean of 12.5 implantation sites and 0. 44 cm
mean implantation size (Table 1).
3.1.2 Aqueous and alcohol extracts
Oral administration of MAP-aq extract at
70 gm DWE/PD1_4 showed normal implantation sites. It was
also noted that the number and size of the implantation
sites was.comparable to that of the control (Table 1).
All animals dosed daily from PD1 to PD4
with MP-EtOH extract (Hong Kong) in 28 gm DWE showed no
implantation site, while a dose of 15.4 gm DWE was half
effective. To determine on which day MP is most effective,
oral doses of MP-EtOH extract (China) were given on various
days before implantation. It is clear that MP is most
effective when given during the peroid of PD1 and PD2. A
lower dose at 5 gm DWE had no apparent anti-implantation
activity. Table 2 showed that when 30 gm DWE of plant
materials (effective on PD1-4), equally distributed to 10
similar doses (3 gm DWE/day) administered during the
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peroid of PD1 to PD10 failed to suppress implantation. There
was no significant difference in the mean number and size
of the implantation sites.
3.1.3 Chloroform fraction
Further purification of MP-EtOH extract by
partition between water and chloroform gave rise to 2
fractions. There was no anti-implantation activity in the
aqueous fraction even at the highest dose level of 100 gm
DWE. The anti-implantation activity was detected in the
chloroform fraction. Oral administration of the chloroform
extract at 20-33 gm DWE/PD1-4 rendered implantation im-
possible (Table 3).
3.1.4 Butanol fraction
Aqueous fraction obtained from partition
between butanol and water of the MP-EtOH extract at a dose
as high as 94.4 gm DWE was ineffective in suppressing
implantation. In contrast, the butanol fraction showed a
dose related anti-implantation activity (Table 4). Significant-
ly smaller implantation sites (range from 0.34-0.37 cm) were
evident in females treated with butanol extract at a dose
level of 60 gm DWE.
3.1.5 Alcohol extract of the aerial parts
The total alcohol extract of leaves and
twigs of MP was toxic to the animal at a dose of 40 gm DWE/
4 days. At this toxic dose level there was no effect on
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Table 1 Anti-implantation Effects of Vehicle, MP Aqueous Root Extract
and Alcohol Extract of the Aerial Parts
Treatment Date of Drug No. Animal with no Implantation Sites at Autopsy
Total Dose in Administration Implantation Site/ Mean No. + S.E. (n) Mean Size + S.E. (n)c
gm DWE Animal Used
(Plant Source)a
Control 0/8 (0%) 11.40 + 0.38 (8) 0.46 + 0.01 (91)
Vehicled PD1-4 0/4 (0%) 12.50 + 0.50 (4) 0.44 + 0.01 (50)
Aqueous root
PD1-10extract 70.0 gin (C) 0/10 (0%) 13.60 + 0.60 (10) 0.46 + 0.01 (136)
MP-Aerial (HK)
PD1-430.0 gm 0/3 (0%) 9.70 + 1.50 (3) 0.42 + 0.02 (29)
PD1-441.6 gm 0/8 (0%)e 12.30 + 0.00 (8) 0.46 + 0.01 (98)
a Plant materials were obtained either locally (HK) or from China (C)
b Autopsy was carried out on PD8
c Length of the long axis of implantation sites in cm
d Received 1 ml of vehicle daily (ig, Ethanol/Tween 80/Water: 2/1/7)
e One animal died on PD2, two died on PD3
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Table 2 Anti-implantation Effects of MP Alcohol Extract
Date of Drug No. Animal With noTreatment Implantation Sites at Autopsy
Total Dose in Administration Implantation Site/ Mean No.+ S.E. (n) Mean Size+ S.E. (n)
gm DWE Animal Used
(Plant Source)a
Control 0/8 (0%) 11.40+ 0.38 (8) 0.46+ 0.01 (91)
PD1-415.4 gm (HK) 0.32+ 0.03 (6)2/4 (5%) 3.00+ 0.00 (2)
PD1-428.0 gm (HK) 8/8 (100%)
PD1-4
PD1-4
76.0 gm(CM20.0 gm(CM) 3/3 (100% 4/4 (100%)
PD1-25.0 gm (C) 0/4 (0%) 12.00+ 1.08 (4) J.44+ 0.03 (48)
PD1-210.0 gin (C) 0/5 (0%) 5.20+ 0.73 (5) 24+0.01 (26)
PD1-215.0 gm (C) 5/5 (1000,
PD1-2
20.0 gm (C) 6/6 (100%)
PD1-10
20.0 gm (C) 0/8 (0%) 9.00+1.51(8) 0.42+ 0.03 (72)
PD3-4
30.0 gm (C) 0/4 (0%) L1.10+ 1.50 (4) 0.38+ 0.03 (44)
a Plant materials were obtained locally (HK), from Chiangmai (CM) or from China (C)













Table 3 Anti-implantation Effects of MP Chloroform Extract
Treatment b No. animal with no Implantation Sites at Autopsy
Total Dose in Implantation Site/ Mean No.+ S.E.(n) Mean Size+ S.E. (n)
gm DWE Animal used(%)
(Plant Source)
Control 0.46+ 0.01 (91)0/8 (0%) 11.4+0.38 (8)
Chloroform Fraction a
0*
33.2 gm (HK) 0*4/4 (100%)
0* 0*70.8 gm (HK) 4/4 (100%)
0* 020.0 gm (C) 5/5 (100%)
0* 0*40.0 gm (C) 7/7 (100%)
Aqueous Fraction a
60.0 gm (C) 0/2 (0%) 12.50+ 2.50 (2) 0.43+ 0.03 (25)
100.0 gm (C) 0/2 (0%) 11.00+ 0.00 (2) 0.32+ 0.02 (22)
a Alcohol Extract was partitioned with chloroform and distilled water to form the
chloroform and aqueous fractions
Plant materials were obtained locally
b The animals were dosed on PD1-4
* P < 0.01, student "t" test
Table 4 Anti-implantation Effects of MP Butanol Fraction
Treatment No. Animal with No Implantation Sites at Autopsy
Total Dose in Implantation Site/ Mean No.+ S.E. (n) Mean Size+ S.E. (n)
gm DWE Animal Used(%)
Control 0/8 (0%) 11.40+ 0.38 (8) 0.46+ 0.01 (91)
Butanol Fraction b
30.6 gm 0/3 (0%) 9.70+ 2.30 (3) 0.37+ 0.02 (29)
50.4 gm 3/5 (60%) 4.50+ 1.50 (2) 0.34+ 0.02 (9)
0 060.0 gm 4/4 (100%)
Aqueous Fraction b
48.0 gm 0/5 (0%) 11.20+ 0.70 (5) 0.45+ 0.03 (56)
94.4 gm 0/4 (0%) 10.00+ 1.10 (4) 0.42+ 0.13 (40)
a Plant Materials were obtained locally
b Alcohol Extract was partitioned with butanol and distilled water to form
the butanol and aqueous fractions
c Animals were dosed on PD1-4
% P 0.01 by Student t test
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Table 5 Confirmation of The Anti-implantation Effects of MP Alcohol Extracta
No. Animal with NoTreatmentb Implantation Sites at Autopsy
Total Dose in Implantation Site/ Mean No.+ S.E. (n) Mean Size+ S.E. (n)
gm DWE Animal Used(%)
Vehicle 0/11 (0%) L3.40+ 0.46 (11) 0.46+ 0.01 (147)
MP-EtOH
32 gm 13/13 (100%)
36 gm to 52m 6/6 (100%)
a The work was performed in the Worcester Foundation for Experiment Biology.
Charles River CD rat was used. Plant extract was obtained from Hong Kong and plant
materials were obtained locally.
b Animal was dosed on PD 1-4







Work performed in Worcester Foundation for
Experimental Biology (Table 5) confirmed that administration
of 32 to 52 gm DWE of MP-EtOH was effective in preventing
implantation.
3.2 Effects of MP on delayed implantation
Animals were treated on PD1 and PD2 with a
total dosage of 10 gm DWE this dosage could reduce the size
of implantation sites observed on day 8 of pregnancy (p<0.01),
but allowed pregnancy to occur (Table 6). The first signs of
implantation were delayed for some 24 hrs. In control animals
the blue reaction become visible in some rats by about 1200
hrs on PD5 and was positive in all the animals studied by
1500 hrs. In treated animals, however, the blue reaction did
not become visible in some rats until midmorning on PD6. By
1400 hrs, there was a positive blue reaction in all the rats
autopsied at this time.
3.3 Uterotrophic effect of MP
The uterotrophic effect of MP-EtOH extract
on spayed rats is shown in Table 7. When animals were treated
daily (for 3 days) with 1 gm DWE of MP-EtOH extract there
was a significant increase in uterine weight. Subcutaneous
injection of 2.5 jig estradiol-17 from day 1-to 3 also
stimulated the uterotrophic response. A significant. difference
in uterine weights was observed between the estradiol-17
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Table 6 Effects of MP Alcohol Extract (MP-EtOH) on
Delayed Implantation
Treatmenta Date of Autopsyb No. of Rats Showing Positive











a Control group and test group received 1 ml of vehicle
or 5 gm DWE of MP-EtOH respectively, (PD1-2, ig)
b Animal was autopsied 10 to 15 minutes after the injection
(iv) of 0.2 ml 0.3% Pontamine Sky Blue in saline
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Table 7 The Uterotrophic Effect of MP Alcohol Extract
(MP-EtOH) and Estradiol-17 on Castrated Rat
Treatmenta Uterine Weight (gm)
Dose/Day X+ S.E. (n)
Vehicle
0.1 ml 45.38+ 0.69 (5)
Estradiol-17
2.5 pg 58.58+ 1.33 (5)
MP-EtOH
1 gm DWE 77.04+ 2.04 (5)
a The animal was dosed once daily from day 1 to day 3,
autopsy was carried out 24 hr after the last dosage
b Vehicle contains Ethanol/Tween 80/Water: 2/1/7
P 0.01
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and vehicle treated animals with a P value less than 0.01.
3.4 Effects of MP on Stimulating Vaginal Cornification
Spayed animals showed a prolonged leukocyte
vaginal smear during the experimental peroid. In contrast,
an estrus smear is typical on the third to fourth day of MP
treatment. Smear patterns with dense cornifed epithelial
cells were found in virtually all of the rats treated daily
with 2 to 5 gm DWE of MP-EtOH extract.
3.5 Effects of Estradiol-17B and MP on the levels of
Estrogen Receptor and Uterine Growth
3.5.1 Nuclear Receptor
No significant difference was observed in
the levels of nuclear receptor site between all controls and
estradiol-17B treated animals in all treatment groups (24 hr,
1 injection: 48 hr, 1 injection and 48 hr, 2 injections).
On the other hand, the pattern of nuclear receptor level of
both MP and MP+E2 groups were similar, administration of MP
or MP+E2 resulted in a moderate increase of nuclear receptor
sites 24 hrs after, followed by a slight depletion in
receptor level as determined at 48 hrs. In 48 hr, 2 inject-
ions group, there was a 4 fold increase in the amount of
nuclear binding sites in rats treated with MP and MP+E2, as
compared to the controls (Fig. 2). However, no additive effect
was observed in animals treated with MP+E2.
3.5.2 Cytoplasmic receptor
Following a single treatment of MP, E., or
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Fig.2 The effect of E2, MP and MP+E2 on nuclear
estrogen receptor content of the uterus.
Immature rats were dosed with A: saline
B: 2.5 ug E2 C: 2 gm DWE MP
D: MP+E2 (E2, ug and MP, 2 gm DWE)
Rats were either killed 24 and 48 hr after treat-
ment or were reinjected at 24 hr and killed
at 48 hr. The-quantity of cytoplasmic estrogen
receptor was determined by the 3H exchange
assay. (Specific activity of 3H estradiol was
101.7 Ci/mmole counting efficiency was 33%).
The vertical bars represent the mean S.E.
of 3 determinations, with 3 rats per determina-
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FIG.3 The effects of E2, MP and MP+E2 on cyto-
plasmic estrogen receptor content of the
uterus. Immature rats were dosed with A:
saline; B: E2; C: MP; D: MP+E2. The
quantity of cytoplasmic estrogen receptor
was determined by the 3H estradiol exchange
assay. The vertical bars represent the mean
+S.E. of 3 determinations, with 3 rats
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The effects of E2, MP and MP+E2 on uterineFIG,4
wet weight. Immature rats were dosed with
A: saline B: E2; C: MP; D: MP+E2. Rats
were either killed 24 and 48 hr after treatment
or were reinjected at 24 hr and killed
at 48 hr. The uteri were weighed. The
vertical bars represent the mean + S.E. of
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FI3, 5 The effects of E2, MP and MP+FE2 on cytosol
protein content of the uterus.
Immature rats were dosed with A: saline,
B: E2, C:MP; D: MP+E,). The cytosol protein
content was determined by the Folin Ciocalteau
test. The vertical bars represenr the mean+




MP+E2, the amount of cytoplasmic estrogen receptor was
slightly increase by 24 hr. A further enhancement was observed
at 48 hr. MP and MP+E2 showed equal potency when given once
or twice within 48 hrs. In the estradiol treated group, there
was a 28% increase by the two dosing schedule (Fig.3).
3.5.3 Uterine weight and cytosol protein content
Animals dosed with MP, E2, or MP+E2, showed
a uterotrophic response (significant increase in both cytosol
protein content and uterine weight) in all treatment group.
Treatment with MP+E2 is superior to that with E2 or MP alone
in the stimulation of uterine growth. Therefore, following
a single or double treatment of MP+E2 by 24 hrs, agonistic
effect is observed (Fig. 4 5).
3.6 Effects of MP on decidual formation
The effect of MP-EtOH on decidual formation
is presented in Table 8.
After 10 to 40 gm DYNE of MP-EtOH extract
given on PSP0-3, none of the fourteen hooded females had
decidualized uteri following oil injection, as opposed to
all 6 of the vehicle treated females. That MP had affected
the normal growth of the pseudopregnant uterus was evidenced
by the drastically reduced mean uterine weight difference
between the two horns in the test group.
The same held true for the unilateral
pregnant animals. It was obvious that in the control group
significant weight increase due to deciduoma formation took
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Table 8 The Effect of MP Alcohol Extract (MP-EtOH) on The Decidual Reaction in
Pseudopregnant and Unilateral Pregnant Ratsa
Total Dose with DeciduoamtaDate ofStatus Response (mgb
gm DWE Administration (No. of Animal Used) X + S.E.
Pseudo-
1130.50 + 239.000 (control)pregnant 100% (6)
10 PSP0-3 5.01 + 6.330% (5)
20 PSP 0-3 3.28 + 8.200% (5)
40 PSP0-3 2.28 + 5.530% (14)
40 1429.00 + 167.00100% (3)PSP4-8
Unilateral
Pregnant 0 1386.40 + 4.75100% (3)
40 PD1-4 4.25 + 6.650% (4)
a Psuedopregnancy was induced by mechanical stimulation of the cervix, while unilateral
pregnant rat was prepared by ligating the left oviduct. The stimulus for deciduoma in-
itiation was provided on PSP4 by injection of 0.05 ml arachis oil into the uterine lumen.
b Response of the psuedopregnant group was represented by the weight difference between
two uterine horns. In the unilateral pregnant group, weight difference between the left
uterine horn of the unilateral pregnant rat and the mean weight of the right horn of the
control pseudopregnant rats (5.22 + 4.38mg (6)) was nqeasured as the response.
+ P > 0.05 by Analysis of Variance
P < 0.001 by Student "t" test
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place in the left horn whereas in the test group there was
no significant difference in weight between the two horns.
When the extract was given on PSP4-8 (i.e. after the oil
injection), it was ineffective in inhibiting decidualization
The weight of all oil injected horns which
had responded formed a homogenous population as shown by
an analysis of variance (p0.05). This agreed with the find-
ings of Finn & Emmens (1961).
The control animals showed a prolonged
leukocyte vaginal smear during the experimental peroid. In
contrast, a proestrus smear is typical on PSP3 of the treat-
ed group. Within the next 24 hrs (i.e. PSP4), a typical
estrus pattern is usually revealed in the vaginal smear.
3.7 Effects of MP on the changes of serum steroid hormone
concentration
Oral administration of MP-EtOH extract at
a dose level of 36 to 52 gm DWE/PD1-4, caused significant
changes in the steroid concentrations (Table 9). This dosage
had been previously tested to be effective in suppressing
implantation. A significant drop in serum estradiol level
was observed on PD3 and PD5 (p<0.05). On the other hand,
serum progesterone level was drastically enhanced only on
PD5 (p<0.01), as compared to vehicle-treated controls on
the corresponding days of pregnancy.
By contrast, in rats after treated with
32 gm DWE, a dose which proved to be effective in suppress-
51
Table 9 Temporal Changes of Seriun steroid concentration in Rats treated with
Vehicle or MP Alcohol Extract
Day of Pregnancy Estradiol-17Treatmenta ( g/ml) Progesterone ( g/ml)
X + S.E. (n) X + S.E. (n)
3Vehicle 32.2 + 4.7 (7) 58.2 + 10.5 (7)
MP-EtOH
32 gm DWE 3 36.3 + 2.8 (6) 44.7 + 5.8 (6)
36 to 52
gm DWE 3 17.4 + 2.1 (5) 114.1 + 27.8 (5)
Control 4 28.4 + 4.2 (5) 90.5 + 7.8 (5)
MP-EtOH
32 gm DWE 4 105.6 + 11.0 (6)31.1 + 3.0 (6)
36 to 52
gm DWE 4 18.3 + 3.5 (5) 103.4 + 8.1 (5)
Control 5 38.3 + 3.9 (7) 86.3 + 11.7 (7)
32 gm DWE 5 36.5 + 2.6 (6) 123.3 + 11.7 (6)
36 to 52 gm
gm DWE 5 256.0 + 51.2 (4)24.6 + 2.8 (4)
a The animal was dosed on PD 1-4* Blood sample was collected during 0900 to 1000 hr on PD 3-b
p < 0.05 by Student "t" test
P < 0.01 by Student "t" test
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ing implantation, serum estradiol level was not altered.
However, changes in the progesterone level were observed.
The hormone increased significantly on PDS (p<0.05, Table 9)
3.8 Effects of exogenous estradiol-17B on MP treated rats
Results indicate that a supplement of a
small dose of estradiol (2.5 or 0.2 iig) to MP treated rats
on PD2 or PD4, failed to abolish the delay of ovum implantat-
ion (Table 10).
3.9 Effects of MP on fetal sex ratio
Results on Table 11 showed that the plant
extract had no adverse effect on either morphogenesis or
fetal sex ratio. All pups were found to be in normal shape
and good health.
3.10 Effects of MP on subsequent pregnancy
In the rats tested for subsequent pregnancy,
the number of implantation sites ranged from 10 to 15, with
a mean of 13.5 to 12.2. The size of the implantation sites
ranged from 0.42 to 0.46 cm, witha mean length of 0.44 to
0.46 cm. Both the number and size of the implantation
sites are comparable to that of the controls (p>0.1, Table
12).
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Table 10 Effects of Exogenous Estradiol-17B on MP Treated Rat
Treatment Date of Estradiol-17B No. of Rats with Implantation
Inection (hr) Site/No. of rat Treated
2.5 ug Estradiol 4/4PD4 (1100)
MPa 0/4
MP+ 2.5 ug Estradiol 0/5PD4 (1100)
MP+ 2.5 ug Estradiol 0/2PD2 (1100)
MP+ 0.2 ug Estradiol 0/2PD2 (1100)
MP+ 2.5 ug Estradiol 0/2PD2 (1600)
MP+ 0.2 ug Estradiol 0/2PD2 (1600)
Total dosage of 32 gin DWE MP-EtOH was administered intragastrically on PD1-4
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Table 11 Effects of MP Alcohol Extract on Fetal Abnormality and Sex Ratio of
The Offspring
RemarkTreatmenta Litter Size Sex of Fetuses
No. Male No. FemaleX S.E. (n)
X S.E. (n) S S.E. (n)
Control 10.6 0.50 (10) 4.8 0.39 (10) All pups were found5.8 0.53 (10)
to be in normal shape
and good health
Test 8 0.54 (4) All pups were found4.75 0.70 (4) 5.25 0.30 (4)
to be in normal shape
and good health
a Test group received 5.0 gm MP alcohol extract on PD1-2
b No significance difference was observed between the control and test group,
P 0.1 by Student t test
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Table 12 Effects of MP Alcohol Extract (MP-EtoH) on Subsequent Pregnancy
Treatment a
Duration of Sterile No. of Implantation Site Size of Implantation Site
Peroid (Day)b
X S.E. (n) X S.E. (n)
S.E. (n)
Vehicle 0 (14 12.93 0.51 (14) 0.52 0.02 (182)
0.45 0.01 (91)c
Test 15.43 0.30 (7) 12.86 0.63 (7)c
a Vehicle group received 1 ml vehicle (Ethanol/Tween 80/Water: 2/1/7)
Test group received a total dosage of 20 gm DWE MP alcohol extract
Autopsy was carried out on PD8
b The duration of PSP was determined by examining the vaginal smear everyday morning
and the day of appearance of proestrus smear was designated as the last day of PSP
c No significant difference between the vehicle and test group, P>0.1 by Student "t" test
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4 DISCUSSIONS
4.1 Suitability of the animal model
4.1.1 Animal type
There are evidences that great
differences exist in the response and sensitivity to the
same drug when tested in different species of animals
(Harper, 1972). Therefore, a plant extract should be
tested on at least two animal models for its anti-implantat-
ion activity. Much of the investigations on contraceptive
screening have been done on rodents. Mouse, however, is
not particularly suitable for this purpose because it is
peculiarly sensitive to the effects of toxic substances. As
little as 18 hrs of starvation during early pregnancy can
prevent implantation in almost all mice (McLure, 1966). Thus,
using mice for such work can lead to many false positive
results. Since the albino rat is relatively economical to
raise and its reproductive physiology the best understood
among many laboratory animal, this species offers the
first choice for primary screening of potential contracept-
ive agents.
Nearly all contraceptive compounds had
first been tested in the rat or mouse, which provided
sufficient interest to initiate studies in nonhuman primates
(Kamboj et al., 1970). However, the endocrinology of
pregnancy of rodents and primates are quite different. For
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example, plasma estrogen levels are low for a day or two
after ovulation in both species, but with the exception of
a brief estrogen surge on day 4 of pregnancy, the levels
of estrogens remain relatively low and stable in the rat
(Yoshinaga et al., 1969). In contrast, estrogens increase
during the luteal phase of the primate cycle and continue
to rise as placental production of this steroid increases.
Thus while estrogen excess is a nonphysiological situation
in rat pregnancy, it is a normal endocrine function of
human and nonhuman primate pregnancy (Hodgen et al., 1972
Vande Wiele et al., 1970). The comparative endocrinology
of pregnancy in primates and rodents always warrants
discrete interpretation and extrapolation of results from
rats in contraceptive screening to human application.
4.1.2 Route of administration
Oral dosing is applied in the present
experiment since it is a convenient and safe route that
is widely used. Because administration of most drugs to
humans is most easily achieved by the oral route, the
majority of chemical agents tested for contraceptive
activity have also been administered orally. However, even
the drug can be absorbed through the digestive tract, it
may cause irritation to the gastrointestinal tract or being
inactivated by the digestive enzymes. Under these circum-
stances, other routes of administration, e.g. subcutaneous.
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intravenous or intramuscular, are more preferable. In any
case, at least 2 routes (one of which should be oral route
of administration) should be tried.
4 .1.3 Dose schedule
Since a drug can act on different
stages of gestation, the first step to screen the anti-
implantation property of a plant extract shall cover the
entire pre-implantation stages. These include a time lapse
between fertilization and implantation, i.e. between day 1
and 4 of pregnancy in the albino rat (Lau et a1., 1973).
4.1.4 Preparation of dosing extract
Hydrophobic extracts, such as those
prepared with low polarity solvents (ethanol, butanol and
chloroform), are almost insoluble in distilled water. For
these types of extracts, alcohol and tween 80 serve as a good
solubilizer and. a suspending agent respectively, but toxicity problems
may involve., It had been concluded that no more than 1/4
of the LD50 of a vehicle should be used in pharmacological
and/or toxicological experiments (Bartsch et al., 1976).
The LD50 of ethanol and tween 80 for albino rat are 13.0
and 30.0 ml/kg body weight, respectively (Berezovskaya
Rudzit, 1976). The amount applied in preparation of the
dosing extract of MP were less than one tenth of their LD50
(0.8 ml/kg body weight for ethanol and 0.4 ml/kg for tween
80).
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However, it is well known that many of
the common vehicles can either enhance or diminish the
biological activity of compounds being evaluated (Bartsch
et al., 1976). In order to eliminate the effect of vehicle
on the anti-implantation potency of the dosing extracts,
another type of vehicle, tragacanth powder (_tra acanth+
starch+ acacia), 10% (w/v), was used as suspending agent.
As the dosing extract prepared by tragacanth powder was
equally effective in suppressing pregnancy, it is likely
that the ani-implantation effect of the dosing extracts
were associated with the inherent properties of the plant
materials.
4.1.5 End point detection
Implantation swellings appear along
the uterine horns by day 6 and prominent implantation sites
can be distinguished easily when autopsied on day 7. The
size of the implantation sites is important in determining
the time of implantation especially when the measurement is
taken 2-3 days after implantation of the blastocysts. If
the size of implantation site is smaller than normal, as in
the case of MP treated rats, the drug might have caused a
delayed implantation (Yoshinaga et al., 1979).
A very early uterine endometrial
change at the site of ovum implantation is the increase
in the permeability of the local capillaries. The change
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can be easily visualized by the accummulation of intra-
venously injected macromolecular dyes, such as pontamine sky
blue. This dye will bind to serum albumin and escape only
through the capillaries with an increased permeability.
The implantaton sites are recognized as blue spots in the
uterus (Psychoyos, 1971). Therefore, this method serves
as a useful technique for determining the timing of ovum
implantation.
4.2 Anti-implantation effect of MP extracts
The aqueous extract, when given
orally at a dose level of 70 gm DUE, failed to prevent
implantation in all treated rats (n=10). The effect of the
alcohol extract, as reflected by the decrease of the number
and size of the implantation sites represents a dose
dependent response, indicating that the effect of the
extract on implantation in the animal is not all or none
in nature. Oral administration of the alcohol extract in
a minimum of 15 gm DWE was effective in preventing implantat-
ion. Purification by partition between chloroform and water
revealed that the active principle is readily soluble in
chloroform. Treatment with aqueous fraction at a total dose
of as high as 100 gm DWE did not affect implantation (Table 3).
The minimum effective dosage of the chloroform fraction is
20 gm DWE, which is comparable to that of the ethanol extract.
Butanol fraction obtained from partition between butanol and
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water is also effective, but the minimal effective dosage of
the butanol fraction is 60 gm DWE. The decrease in potency
may be due to the loss of active ingredient(s) or insuffici-
ent extraction into the butanol phase during the butanol/
water partition step.
In summary, the active principle is




Like the effect of estrogen, a sus-
tained increase (48 hrs) in uterine weight was observed in
intact immature rats orally dosed with HP (Fig5). With the
MP extract, an antifertility effect is produced at a dose
level (15 gm DATE) which is greater than that in stimulating
uterine growth (2 gm DWE). The same property is observed in
many of the conventional estrogens (Pincus et al., 1964).
4.3.2 Vaginal cornification
MP acts as a potent estrogen and is
evidenced by the stimulation of vaginal cornification in
pseudopregnant rats. It is also effective in producing
vaginal cornification in ovariectomized rats at a dose level
of 2 gm DWE only.
4.3.3 Estrogen or antiestrogen?
The effects of exogenous estrogen on
fertility has been extensively studied (Parkes Bellerby,
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1926; Dreisbich, 1959 Greenwald, 1961) and it was stated
that any compound with estrogenic activity may have anti-
fertility effect if taken at a particular time soon after
mating (Chang & Yanagimachi, 1965).
However, there seems to be a high
correlation between estrogenic and antiestrogenic activity
(Emmens et al., 1964). It is recognized that under certain
circumstances, antiestrogens also exert an estrogenic effect
on uterus, for example, nofoxidine, can increase uterine
weight when injected into immature rat, but when it is used
simultaneously with typical estrogen agonist, it display an
antagonistic effect Katzenellenbogen Ferguson, 1975).
This correlation has made it difficult to decide whether the
antifertility activity shown by many of these antiestrogens
is due to their estrogenic or antiestrogenic action
(Martin et al., 1963 Emmens et al., 1964). It was suggest-
ed that antiestrogens antagonize estrogen-induced uterine
growth as a result of their failure to stimulate the replen-
ishment of the cytoplasmic estrogen receptor (Clark et al.,
1974). Nafoxidine causes accurnmulation and long term retent-
ion of the nuclear receptor complex. However, this retention
is not accompanied by the usual replenishment of cytoplasmic
receptor, as in the case after estradiol treatment. This
failure to stimulate the replenishment of cytoplasmic recept.
or may render the uterus insensitive to subsequent injection
of estrogen, and therefore, antagonism can be observed.
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In order to evaluate the agonist/
antagonist properties of MP, the effects of MP and MP+E2 on
nuclear and cytoplasmic receptor content and on uterine
growth are studied. In the present experiment, the animal
received serial doses of MP at 24 hr intervals. This method
has been used routinely by many investigators, and that
estrogen antagonism can be observed under these conditions
(Callantine et a1., 1966 Clark et al.,1977). As the recept-
or antagonist complex fails to cause the replenishment of
cytoplasmic receptor, when the animal receives a second
dose of estrogen of this time, the uterus is unresponsive
in the animals that received the antagonist but is highly
responsive in the estradiol treated animals. Therefore, the
uterus continues to grow in the estrogen treated rat and
remains unstimulated in the antagonist treated animal.
It was demonstrated by Katzenellenbogen
(1975) that following a single injection of E2 (5 ug), the
level of nuclear estrogen receptor was maximal by 1 hr,
declined rapidly to levels only slightly above control by
4 hrs and remained at this level until as long as measured
thereafter (42 hrs). The present data confirms the observat-
ions of Katzenellenbogen there was no significant difference
in the level of nuclear receptor sites between the controls
and E2 treated animals, whereas a prominant increase in
cytoplasmic receptor was observed (Fig 2 & 3).
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in contrast to the short nuclear
residency of the estradiol-receptor complex, MP causes
nuclear retention of the receptor for long periods of time
(48 hrs, fig 2). This stimulation in uterine growth is
superior to that of estradiol in magnitude and the length
of time of growth stimualtion (Fig 4 5). Therefore, MP
is similar to nafoxidine, a long acting estrogen (Clark
et al., 1972 1973), causing growth stimulation and
nuclear retention of the receptor which exceed that induced
by estradiol (Clark et al., 1973 1974 Rochefort et a1.,
1972). It is likely that the active principle(s) of MP are
cleared slowly from the body, and cause nuclear retention
of the receptor for much longer periods than estradiol.
However, unlike nafoxidine, MP nuclear
receptor complex stimulates full replenishment of cytoplasm-
ic receptor, whereas the nafoxidine receptor complex fails to
cause the replenishment by 24 hrs (Clark et al., 1972 1973).
When the animal receives a second dosage of MP after 24 hrs,
the uterus continues to grow and no estrogen antagonistic
effect was observed in the MP treated animals, after a single
or a double treatment. The quantity of cytoplasmic receptor
in MP or MP+E2 treated rats were elevated by 48 hrs (1 or 2
injections). This replenished cytoplasmic receptor is then
free to interact with estrogen to form receptor hormone com-
plexes which bind to nuclear sites and cause a second cycle
of uterine growth stimulation.
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4.4 Action mechanisms
Laboratory evidence reveals that MP,
being a potent estrogen, is an effective interceptive agent
if given during the immediate post-ovulatory period. It is
likely that MP may act through the following routes:
acceleration in tubal transport of ova, a direct blasto-
toxic effect, suppression of luteal function, or an
imbalance in the hormonally directed progression of
endometrial changes necessary for implantation.
4.4.1 Effects of MP on oviductal transport
Plant extracts that are effective on
PD 3-4 may have some effects on the uterine environment
which becomes hostile to the developing embryos, and those
only effective on PD4-5 will cause hormonal disturbance,
resulting in a failure of implantation process, since MP
is effective only on PD1-2, it would appear that egg
transport is being affected. It was reported that estrogen
given during the peroid of tubal transport of eggs can be
extremely effective as postcoital antifertility agents. Once
the egg has entered the uterus, more estrogen is required
to prevent pregnancy, and after implantation, at least in
primates, effectiveness is completely lost (Morris et al.,
L971 1973). It may be that the hormone exerts its maximum
affect on oviduct motility and egg transport. In all species
so far examined, estrogen has been shown to disturb egg
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transport (Greenwald, 1967; Humphrey, 1968; Harper, 1967;
Banik & Pincus, 1964).
In order to distinguish whether the
drug acts directly on the embryo or the anti-implantation
effect is mediated through the adverse effect of the drug
on the uterus, the ovum transfer technique may be applied
(Smith, 1968; Wu & Meyer, 1970). The main disadvantage of
this technique is the technical skill required and the time
comsumed to perform it, which makes large scale experiments
very time consuming and difficult to control. The blasto-
cyst is a very sensitive living organism and even under
ideal circumstances, one rarely gets all the transplanted
ova implanted. Owing to the technical difficulty of obtain-
ing satisfactory percentage of ovum recovery in oviduct
flushing, the possibility of MP acting on oviductal transport
cannot be further confirmed.
4.4.2 Effects of MP on decidual formation
Besides the ovum transfer technique,
however, a much simpler method, i.e. the use of an artific-
ial stimulus to induce decidualization in the uterus, can
be applied. By using this as a model, it is able to rule
out any effect on the eggs, and also to get more accurate
information on the time relationships of the sensitivity of
the uterus to these substances. It has been shown in rats
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that estrogen can have a direct inhibitory effect on
implantation after the period of tubal transport, by
preventing or delaying the increase capillary permeability
of the uterus or by interfering with the ability of the
stromal cells of the endometrium to undergo decidualization
(Harper, 1968a).
Result. shows that MP, in a dosage
of 10 gm DWE, is effective in inhibiting decidual formation.
Yet, it cannot be determined whether this effect on the
uterus is responsible for the antifertility effect of MP
because the effective dosage for inhibiting deciduoma
formation (10 gm DWE) is considerably less than the dosage
required to prevent implantation (15 gm DWE, compare table
2 8). This property is also observed in other estrogenic
compounds, such as dienestrol (Harper, 1968a, diethylstil-
bestrol (Finn Emmens, 1961), androstenedione (Harper,
1967) and clomiphene (Stapes, 1966). It is probable
that the hormone conditions of pseudopregnancy and decidual
cell production which is induced by cervical stimulation
and oil injection of the uterus are not quantitatively the
same as those of true pregnancy. Possibly the developing
blastocyst supplies some stimulus to decidual cell product-
ion which is more resistant than the stimulus of oil
injection to interference by hormones or similar substances
(Finn, 1966). Therefore, a higher dose is required to inhibit
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pregnancy than decidualization.
The weight of all oil injected horns
which had responded formed a homogenous population as
shown by analysis of variance (p>0.1). From this, it can
be seen that the inhibition is all or nothing in nature and
the compounds are inhibiting some mechanism which triggers
the decidual response, rather than inhibiting the actual
development of the decidual cells. Work by Finn (1966)
showed two ways in which relatively small amounts of
estradiol at certain stages can upset the sensitization of
the uterus for implantation. This may account for the all
or nothing nature of the inhibition. Suppression happens
when either the level of estrogen at the time of the nidat-
ory estrogen surge rises above the concentrations at which
an inhibitory effect occurs, or if given before this time,
premature sensitization is induced followed by a refractory
state so that the natural surge is ineffective. In normal
circumstances the small surge of estrogen just prior to
implantation causes some change in the uterus necessary for
the decidual response. This change is histamine release from
the mast cells (Finn Emmens, 1961). Administration of
estrogen before this natural surge could initiate such a
change prematurely, and ineffectively, because the egg
would not have developed sufficiently to implant. In doing
so it could deplete the uterus of the substance concerned,
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perhaps histamine, thus rendering it unable to respond to
the later endogenous surge of-estrogen. Estrogens have been
shown to cause release of histamine from the uterus and
depletion of mast cells (Ferrando Nalbandov, 1968).
4.4.3 Effects of MP on the changes in serum hormone levels
Results indicate that MP is effective
in delaying implantation of the ovum. If these disturbance
of early pregnancy are caused by or related to a hormonal
imbalance, the effect of MP on pregnancy may be, at least,
partly attributed to an indirect effect through the endo-
crine system. In order to investigate this possibility,
serum concentrations of l_ P and E2 were evaluated during
the period of PD3-5'
As shown in Table 9, serum levels
of the two steroids, 4P and E 2 in control rats are
comparable to those reported by Yoshinaga (1979) on the
corresponding days of pregnancy.
As the onset of this study, we
assumed that delayed implantation in MP-treated rats might
be due to a low E2 level. This assumption was based on the
well established endocrine background of delayed implantat-
ion in lactating pregnant rats the delay is caused by low
levels of E2 (Krehbiel, 1941 Weichert, 1941 Yoshinaga,
1961). This was further confirmed by the results obtained
from radioimmunoassay, that estradiol levels were lower
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(significant on PD3 and PD5) in MP treated rats (in a
dosage of 36 to 52 gm DWE) than in controls. On the contrary,
for rats treated with 32 gm DWE of MP, a dose which was
proved to be 100% effective in terminating pregnancy,
however, no difference in serum E2 levels was observed. This
suggests that insufficient secretion of E2 during early
pregnancy may not be the cause of delayed implantation in
MP treated rats.
In Table 10, results show that the
anti-implantation action of MP cannot be inhibited to any
extent by the administration of exogenous E2. The doses of
E2 used (2.5 or 0.2 ig) are quite considerable and in rats
treated with 2.5 ug E2, implantation sites are found in
100% (4/4) of rats. The failure of E2 administered on PD2
or PD4 to restore normal implantation, supports the view
that the effect of MP at this time is not due to its E2
depleting action.
There was an increase in serum 4P
levels on PD3 and PD5. However,'the enhancement are again
associated with the high dose treated group and a significant
difference is only observed on PD5. Therefore, it cannot be
determined whether an increase of 4P secretion is responsible
for the delay in ovum implantation in MP treated animals.
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4.5 Teratogenic effects of MP
4.5.1 Sex ratio
In addition to requirements of effect-
iveness, interception involves the risk that if taken in
marginal doses or at marginal times, the compound may prove
teratogenic. Teratogenesis has been noted with a variety of
interceptive agents, such as U11100A, U11555A and para-
hydroxypropionphenone (Morris, 1970). However, no terato-
genicity (other than virilization with androgens) has been
observed with any steroid, including estrogen. MP, being
a potent estrogen, also exhibits no adverse effect on the
development of the fetuses.
Since gonadal abnormalities were
observed in rabbit fetuses after in vitro treatments of
fertilized eggs with P'2 and stilbestrol, it is of interest
to study the effects of MP on abnormality of rat fetuses,
and results indicate that no virilization effect is observed.
4,5.2 'Subsequent pregnancy
Apparently normal mating and pregnancy
occurred after the pseudopregnancy consequent of MP admin-
istration. That the sterile period induced a pseudopregnancy
Ls confirmed by persistent leukocytic smear pattern. There
thus appears to have no carryover of the sterilizing action
of MP. This effect is similar to many of the estrogen
analogues, as reported by G. Pincus (1964).
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4.6 General discussions
In the present study, the anti-
implantation activity of MP is evaluated. It is most
effective when given on PD1-2 and is not active on PD3
or thereafter. Half of the minimal effective dose required
to suppress implantation is strong enough to stimulate
vaginal cornification. Estradiol and estrone possess
similar characteristics with MP: when given on PD1-2,
the two hormones cause retention of eggs in the oviduct
and interfere with the uterine reaction (Edgren & Shipley,
1961). Hence, it is likely that the effect of MP on early
pregnancy in rat is due to its inherent estrogenicity.
It is shown that MP not only
influenced the endocrine system, but also inhibit the
decidual formation and most likely interfere with oviduct-
al transport. Therefore the anti-implantation effect of
MP can be of diverse nature, They are closely interrelat-
ed rather than independent events, but the relations
between one another are still not clear. Possibly, prevent-
ion of pregnancy after MP treatment on PD1-2 may be solely due
to. a 'tube locking' of eggs in the oviduct. Ova developing
asynchronously with the uterus will degenerate if the
endometrium is 'older' than the egg (Noyes Dickmann,
1960). Furthermore, at the time of implantation, inhibition
of decidual formation may play a role in the termination
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of pregnancy, A significant difference in the serum
concentration of E 2 and 4P is observed between controls
and MP treated rats, To what extent this altered serum
hormone level induced by MP affects the oviductal trans-
port and uterine sensitization awaits further investi-
gations, In order to elucidate the whole action spectrum
of MP on ovum implantation, studies on the rate of ovum
transport and blastotoxic effect by the ovum transfer
technique seem inevitable. Moreover, histological studies
of the uterus during the period of implantation will
clarify the effect of MP on the orientation of blastocyst
and on uterine preparation,
Apart from these considerations,
investigation using isolated components of the drug will
definitely give more meaningful answers. Since crude
extract of MP is used in the present experiments, it is
indispensable to determine whether there is one or more
active principle(s) involved and whether it is these compounds
or their metabolites that brought about the physiological
responses in the treated animals, Isolation of the active
component (s) is now in progress,
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5 SUMMARY
1. The effects of Murraya paniculata extracts on implantat-
ion were investigated in the rat. Oral administration of
MP-EtOH in a minimum of 15 gm DWE was effective in
suppressing implantation. The effective dosage of the
chloroform and butanol fractions were 20 and 60 gm DWE,
respectively.
2. MP was most effective when given on PD1-2 and was not
active on PD3 or thereafter.
3. Ovum implantation was delayed for approximately 24 hrs
in MP treated rat.
4. Like the effect of estrogen, MP produced a sustained
increase in uterine weight in intact and ovariectomized
immature rat. It stimulated vaginal cornification in both
pseudopregnant and ovariectomized rat.
5. MP produced a long term retention of nuclear estrogen receptor
parallelled with a full replenishment of cytoplasmic
receptor.
6. MP, in a dosage of 10 gm DWE, was effective in inhibit-
ing decidual formation.
7. Concentrations of E2 in serum were significantly reduced
in MP treated rat on PD3 and PD5. On the other hand,
serum concentrations of 4P were significantly increase
in MP treated rat on PD5.
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8. A single injection of E2 on PD2 or PD4 failed to
abolish the anti-implantation effect of MP.
9. MP exhibited no adverse effect on the development of
the fetuses.
10. Normal mating and pregnancy occurred after the
pseudopregnancy consequent after MP administration.
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